Establishing a Primary Care Plan for Your Patient
Bonnie Boyette Peterson, ARNP

This session will describe the baseline laboratory testing that is recommended for all patients entering HIV care as well as recommended follow-up screenings. The speaker will address tailoring the monitoring plan for the patient based on pertinent co-morbid conditions, and whether the patient is currently receiving antiretroviral therapy or not. The speaker will summarize the Primary Care Guidelines for the Management of Persons Infected with HIV from the HIV Medical Association of the Infectious Diseases Society of America, as well as recommendations from the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents from the Department of Health and Human Services. 
(Handouts)

Opportunistic Infections and Vaccines
Jennifer Janelle, MD

Prevention and early recognition of opportunistic infections (OIs) is important to prevent complications in HIV-infected patients. The speaker will summarize the indications and recommended regimens for primary prevention of opportunistic infections and vaccines recommended for HIV-infected patients. Patient case discussions will be used to assist the clinician in recognizing the signs and symptoms of some of the most common opportunistic infections. The speaker will describe resources available to assist the clinician in prevention and treatment of OIs, including the Opportunistic Infection pocket card recently developed by the Florida/Caribbean AETC.
(Handouts)

The Dental Exam
Micaela Gibbs, DDS

Lack of optimal funding for dental services often prevents the availability of recommended dental care for our HIV-infected patients. This session highlights the importance of recognizing dental issues that may contribute to deleterious health events, such as cardiovascular disease and stroke. The audience will learn the basics of an office dental exam, as well as the education that should be given to our patients to decrease the potential dental pathology that will negatively impact their health.
(Handouts pending approval)

Designing the 1st Regimen
Don Kurtyka, ARNP, PhD

Choosing an initial HIV regimen seems simple given the guidance of the Department of Health and Human Services Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. This session will clarify the complex issues that must be taken into account to assure the successful initiation of the first ARV regimen. The speaker will describe factors to consider in the decision making process, including patient readiness, co-morbid conditions and concomitant medications.  
(Handouts)

Drug Interactions
Michael Thompson, PharmD, BCNSP

Detection and management of potential drug interactions can be challenging for providers who care for HIV-infected patients. Due to the effects on hepatic metabolism and other factors, there are many potentially serious drug interactions among antiretroviral agents, agents used to prevent or treat opportunistic infections, and agents used to manage co-morbid conditions in the HIV-infected patient. This session will review the most common potential drug-drug interactions encountered when managing HIV-infected patients and the speaker will describe clinical resources available. 
(Handouts)

Complications of ARVs
Antonio J. Carrion, PharmD

While antiretroviral (ARV) therapy has significantly prolonged the lives of patients infected with HIV, the benefits of ARV therapy do not come without potential risks. The clinician needs to be aware of the potential complications of antiretroviral therapy in order to properly manage patients and minimize these risks. A series of audience response system questions will be used to identify the most common or severe potential adverse effects and complications of antiretroviral therapy.
(Handouts)

Hepatitis Coinfection
Jeffrey Beal, MD, AAHIVS
Maribel Gonzalez, MS, ARNP, FNP-C

Hepatitis B and C coinfection in the HIV-infected patient result in significant increase in cost, as well as earlier morbidity and mortality. Too few Hepatologists are willing to provide care and treatment for this population, necessitating the development of expertise among the Ryan White funded programs to manage these issues for their patients. This session focuses on using tools to assist the HIV practitioner new to the treatment of these diseases. The speaker will discuss care of the patient from evaluation for therapy through managing side effects and resistance to treatment. A provider from a rural area will discuss the usefulness of the Florida/Caribbean AETC tools developed to assist in the care and management of these patients.
(Handouts)

Resistance Testing Fundamentals
Nobel A. Bellosillo, MD

Using animated video, the learner will visually see and understand the complex interactions of this virus with its host and with the drugs we use to combat the resultant immunosuppresion. Mechanisms of resistance are highlighted providing a visual understanding of the development of newer therapeutics to attack the life cycle of HIV.
(Handouts)

Designing Regimens for ARV-experienced Patients
Joanne J. Orrick, PharmD, AAHIVE

This session will review the fundamentals of managing treatment-experienced patients. Patient case discussions will be used to describe the process of choosing second or third antiretroviral regimens in treatment-experienced patients who have developed resistance to one or more antiretroviral regimens. The speaker will describe tools available to assist clinicians in managing treatment-experienced patients.
(Handouts)

Mycobacterial Infections in HIV
Jose Montero, MD

Tuberculosis, Atypical Mycobacterial Infections and Immune Reconstitution Inflammatory Syndrome will be reviewed, including the basics of diagnosis and treatment, as well as prevention within the HIV-infected population. Critical to this discussion is the recognition of drug interactions that can occur while in the midst of treatment of these complicated infectious diseases.
(Handouts)

STD Patient Case Presentations
John F. Toney, MD

A series of patient case presentations will be used to describe the clinical presentation and management of selected sexually transmitted diseases (STDs) in HIV-infected patients. The speaker will describe resources available to assist the clinician in managing STDs including the STD poster recently developed by the Florida/Caribbean AETC in collaboration with the Southeast Region STD/HIV Prevention Training Center.
(Handouts)